Navigation Links
Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease

nt and chief scientific officer at Lexicon and an author on the paper. "The research our team published today may be an important first step in the development of a new treatment for severe cardiovascular disease, which continues to be the leading cause of death in the United States."

Earlier this year, researchers at the University of Texas Southwestern Medical Center in Dallas, the Institute of Molecular Medicine at the University of Texas Health Science Center in Houston, and other collaborating institutions found that individuals with a mutated ANGPTL4 gene have significantly lower triglyceride levels and higher levels of HDL cholesterol (or "good" cholesterol).(1) These results from human genetic studies further support Lexicon's therapeutic strategy based on original observations made using animal models.

Lexicon scientists discovered ANGPTL4's utility as a potential cardiovascular disease target as part of its Genome5000(TM) program, and the discovery was selected for inclusion in its collaboration with Genentech, Inc. The collaboration with Genentech was initiated in December 2002 to discover the functions of secreted proteins and potential antibody targets identified through Genentech's Secreted Protein Discovery Initiative (also referred to as the SPDI program), and was expanded in November 2005 to include the advanced research, development and commercialization of new biologic drugs. Under the collaboration, Lexicon has the right to develop and commercialize biotherapeutic drugs for up to six targets. Genentech retains an option on the potential development and commercialization of the biotherapeutic drugs that Lexicon develops from the collaboration under a cost and profit sharing arrangement. ANGPTL4, referred to internally as LG842, is one of two targets already chosen by Lexicon for internal development. Lexicon has already generated versions of ANGPTL4 monoclonal antibodies that are currently in preclinical evaluation to identify a pote
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
2. Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
3. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
4. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
7. Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
8. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
9. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
10. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
11. Point of Care Strep Tests Speed Treatment, Lower Costs
Post Your Comments:
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... OAKS, Calif. , May 29, 2015 /PRNewswire/ ... pooled data from two pivotal Phase 3, global, ... calcimimetic, for the treatment of secondary hyperparathyroidism (SHPT) ... hemodialysis. Both studies met the primary endpoint, demonstrating ... AMG 416 groups achieved a greater than 30 ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... MOUNTAIN VIEW, Calif., April 4, 2011 VIVUS, Inc. (Nasdaq: ... patients treated with the investigational drug QNEXA® for two years ... medications as well as improvements in lipid levels following significant ... placebo group over two years. The data ...
... community pharmacy chain, has revealed that one in four* (24%) of ... has taken or applied medicines which they later discovered were out ... (53%) of people do not always check the expiry date of ... This is worrying considering that nearly one in ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3
(Date:5/29/2015)... Astoria, NY (PRWEB) May 29, 2015 Thursday, ... United States. People from all walks of life came ... , Because Red Nose Day is a campaign dedicated to ... by simply having fun and making people laugh, the people ... their clinic in Astoria. Here they provided food, fun ...
(Date:5/29/2015)... Acoustiblok recently resolved a noisy well motor issue ... Municipal Water District (Three Valleys MWD) in California. Ben ... project said, “The new Acoustiblok All Weather Sound Panels ... better looking than the temporary barriers. We are pleased ... the process, and the customer service was great.” , ...
(Date:5/29/2015)... May 29, 2015 New England ... the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and ... a new product line of peptide stable isotope ... Tryptides™, or isotope labeled tryptic peptides, offers thousands ... and is now readily accessible to the biomedical ...
(Date:5/29/2015)... On May 28th, TheCelebrityDresses.com released their new range ... dresses. Most of the styles in their new collection ... than 80 styles of sexy cocktail dresses and 100 ... elements coming with the new release are color blocks, ... Many of the new styles are made of carefully ...
(Date:5/28/2015)... Kentucky (PRWEB) May 29, 2015 On Monday, ... its newest location at 160 Frankfort Road in Shelbyville, Kentucky ... oversee all operations as well as treat patients , ... provide a more convenient , local clinic to better serve ... patients first making their experience as trouble-free as possible by ...
Breaking Medicine News(10 mins):Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3
... of health care reform in the U.S. Senate is one historic ... will make to every person living in this country: If you ... to afford coverage and insurance companies will not run roughshod over ... include final passage after conference committee, effective implementation in the years ...
... embryonic-like cells, study finds , THURSDAY, Dec. 24 (HealthDay News) ... common cold and heal wounds, but the antioxidant might have ... stem cells, new research suggests. , The findings, published ... , add to previous research that showed how adult cells ...
... Dec. 24 The U.S. Senate bill,s historic expansion of ... of the health care system to the medical and insurance ... and state governments to monitor and police these industries and ... While the legislation requires every American to buy coverage under ...
... Speaker Nancy Pelosi issued the following statement this morning ... health insurance reform legislation: , "Today,s vote in ... affordable health insurance to every American. I commend Senator Reid ... a critical step on behalf of the health and security ...
... , WASHINGTON, Dec. 24 The following statement ... Association: , "Today, the Senate took an historic vote ... to millions of Americans and strengthening the private insurance market ... The AMA supported passage of the bill because it contains ...
... FOUNTAIN VALLEY, Calif., Dec. 24 Today Zealous, Inc. (OTC ... stake in Zealous Interactive in order to monetize the valued ... Gottlieb said, "We are in detailed talks with a major ... marketing assets owned by Zealous Interactive, a wholly owned subsidiary ...
Cached Medicine News:Health News:A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 3Health News:AMA: Senate Bill Passage Historic, More Work to Do in Conference 2Health News:Zealous in Talks to Sell Its Interactive Subsidiary; Company Said to be Considering All Options. 2
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... This table is designed ... in many procedures, allowing for ... auxiliary leg is stored onboard ... Post brackets quickly slide ...
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
Light weight, clear imaging, attaches easily, perfect size, optional leg, table cart....
Medicine Products: